Literature DB >> 1608537

Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study.

A R McQuiston1, W F Colmers.   

Abstract

Neuropeptide Y (NPY) has been reported to inhibit excitatory neurotransmission in hippocampus presynaptically. Recently, it has been suggested that NPY also potentiates N-methyl-D-aspartate (NMDA)-mediated excitatory responses in hippocampus, by action at a sigma or phencyclidine (PCP) binding site. We tested this hypothesis by examining the action of NPY on CA3 pyramidal cells using slice-patch voltage clamp recordings. NPY did not affect inward currents elicited by iontophoresis of NMDA onto the proximal dendrites of these cells under two different conditions, but did reduce the excitatory postsynaptic currents elicited by mossy fiber stimulation. NPY therefore does not appear to directly alter the postsynaptic NMDA response in CA3 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1608537     DOI: 10.1016/0304-3940(92)90929-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.

Authors:  R Bergeron; G Debonnel
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

2.  NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro.

Authors:  Nina Pronchuk; William F Colmers
Journal:  Br J Pharmacol       Date:  2004-02-16       Impact factor: 8.739

3.  Neuropeptide Y and Epilepsy.

Authors:  William F. Colmers; Bouchaïb El Bahh
Journal:  Epilepsy Curr       Date:  2003-03       Impact factor: 7.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.